ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Pulmonary Disease

Top Pulmonary Disease Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ANAND BHUPTANI MD

Pulmonary Disease

7,283

$744K

741
471 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 56%

$102
Average prescription price

Avg: $185

AJAY DESHPANDE MD

Pulmonary Disease

7,258

$1.54M

645
385 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

48%
prescriptions for brand name drugs

Avg: 56%

$213
Average prescription price

Avg: $185

DAVID ROE M.D.

Pulmonary Disease

5,612

$776K

165
71 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

28%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 56%

$138
Average prescription price

Avg: $185

DAVID WILSON MD

Pulmonary Disease

5,409

$1.7M

727
495 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

73%
prescriptions for brand name drugs

Avg: 56%

$314
Average prescription price

Avg: $185

ROBERT DALY MD

Pulmonary Disease

5,284

$662K

498
417 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 56%

$125
Average prescription price

Avg: $185

KRISHNA MURTHY M.D.

Pulmonary Disease

5,263

$292K

216
179 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 56%

$55
Average prescription price

Avg: $185

WILLIAM HOUSER M.D.

Pulmonary Disease

5,016

$540K

528
432 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 56%

$108
Average prescription price

Avg: $185

WALID SAMAAN M.D.

Pulmonary Disease

4,941

$344K

484
281 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 56%

$70
Average prescription price

Avg: $185

RAMESH PATEL MD

Pulmonary Disease

4,541

$538K

376
293 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 56%

$118
Average prescription price

Avg: $185

JAMES PIKE D.O.

Pulmonary Disease

3,913

$254K

407
321 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 56%

$65
Average prescription price

Avg: $185

DAVID MARES MD

Pulmonary Disease

3,779

$586K

315
204 are 65+

5%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 56%

$155
Average prescription price

Avg: $185

JAMES DOWNING M.D.

Pulmonary Disease

3,697

$620K

317
191 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

7%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 56%

$168
Average prescription price

Avg: $185

DANA REIHMAN MD

Pulmonary Disease

3,538

$752K

484
359 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 56%

$213
Average prescription price

Avg: $185

LAWRENCE DULTZ M.D.

Pulmonary Disease

3,262

$769K

386
266 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 56%

$236
Average prescription price

Avg: $185

MAY LEE M.D.

Pulmonary Disease

3,203

$318K

243
184 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 56%

$99
Average prescription price

Avg: $185

CHARLES KINSELLA M.D.

Pulmonary Disease

2,775

$967K

393
305 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

80%
prescriptions for brand name drugs

Avg: 56%

$348
Average prescription price

Avg: $185

WESLEY RATLIFF MD

Pulmonary Disease

2,692

$288K

319
240 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 56%

$107
Average prescription price

Avg: $185

BAQHAR MOHIDEEN MD

Pulmonary Disease

2,560

$306K

249
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 56%

$120
Average prescription price

Avg: $185

LEONARD BUCCELLATO MD

Pulmonary Disease

2,474

$823K

302
261 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 56%

$333
Average prescription price

Avg: $185

NARESH UPADHYAY MD

Pulmonary Disease

2,433

$178K

175
107 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 56%

$73
Average prescription price

Avg: $185

HAKAM SAFADI M.D.

Pulmonary Disease

2,422

$364K

272
194 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 56%

$150
Average prescription price

Avg: $185

ROBERT SHELLMAN M.D.

Pulmonary Disease

2,372

$632K

287
201 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

69%
prescriptions for brand name drugs

Avg: 56%

$267
Average prescription price

Avg: $185

EUSTACE FERNANDES MD

Pulmonary Disease

2,370

$944K

309
226 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 56%

$398
Average prescription price

Avg: $185

SHARON HARIG MD

Pulmonary Disease

2,340

$303K

321
278 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 56%

$130
Average prescription price

Avg: $185

ELIAS KAKISH MD

Pulmonary Disease

2,218

$360K

320
246 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 56%

$162
Average prescription price

Avg: $185

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank